Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
613.00    6.00 (0.99%)
Bid:
610.00
Ask:
612.00
Spread: 2.00 (0.328%)
Market Cap: £680.28m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

2 Aug 2017 07:00

RNS Number : 8057M
Barr(A.G.) PLC
02 August 2017
 

IMMEDIATE RELEASE 2 August 2017

 

A.G. BARR p.l.c. 

 

("A.G. BARR")

 

Trading Update 

 

Revenue up 8% and Group on track to meet full year profit expectations

 

A.G. BARR, which produces and markets some of the UK's leading drink brands, including IRN-BRU, Rubicon, Strathmore and Funkin, today announces a trading update in respect of the 26 weeks ended 29 July 2017.

 

We are pleased to report a strong first half sales performance supported by the continued success of last year's new product launches. Revenue for the 26 weeks ended 29 July 2017 is expected to be £136m, an increase of c.8% on the same period in the prior year (2016: £125.6m).

 

This strong sales performance was delivered against a market backdrop that saw value increase by 3.5% and volume by 2.1% (Source: IRI UK soft drinks market data from 29 January to 18 June 2017). 

 

In the first half we increased our investment in support of our innovation and brand growth activity. This, combined with slightly later than anticipated phasing of price increases and generally higher operating costs, including the effect of weaker sterling on input costs, had a moderate impact on margins during the period.

 

We are making good progress with our sugar reduction programme and are confident that we will meet the portfolio target communicated in March 2017. We expect this programme to be completed by the end of the financial year (January 2018) as the reformulated products are phased in across the next six months.

 

Outlook

 

While the wider economic environment continues to be uncertain, we have a clear strategy and a strong commercial plan in place, and we remain confident that we will deliver a full year financial performance in line with the Board's expectations.

 

Roger White, Chief Executive Officer, commented:

 

"We have delivered a good first half with strong sales growth supported by our successful innovation programme, particularly IRN-BRU XTRA, which has now been launched in England and Wales, and Rubicon Spring, which is gaining distribution across multiple channels. We are well positioned to deliver against our expectations across the balance of the year."

 

 

For more information, please contact:

 

A.G. BARR 01236 852400

Roger White, Chief Executive

Stuart Lorimer, Finance Director

Instinctif Partners 020 7457 2020

Matthew Smallwood

Justine Warren

 

Next update: Interim Results - 26 September 2017

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUPARUPMGAG
Date   Source Headline
11th Jul 202210:32 amRNSDirector/PDMR Shareholding
16th Jun 202210:14 amRNSDirector/PDMR Shareholding
16th Jun 202210:04 amRNSDirector/PDMR Shareholding
15th Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:42 pmRNSDirector/PDMR Shareholding
13th Jun 20221:40 pmRNSDirector/PDMR Shareholding
8th Jun 20229:53 amRNSDirectorship
27th May 20221:55 pmRNSResult of AGM
23rd May 20229:55 amRNSDirector/PDMR Shareholding
11th May 20228:53 amRNSDirector/PDMR Shareholding
26th Apr 20229:08 amRNSAnnual Financial Report / Notice of AGM
11th Apr 20221:11 pmRNSDirector/PDMR Shareholding
11th Apr 20228:51 amRNSDirector/PDMR Shareholding
11th Apr 20228:45 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSDirectorate Change
29th Mar 20222:34 pmRNSDirector/PDMR Shareholding
29th Mar 20229:37 amRNSCorrection: Final results year ended 30 Jan 2022
29th Mar 20227:00 amRNSFinal results for the year ended 30 January 2022
18th Mar 20229:02 amRNSHolding(s) in Company
8th Mar 20222:14 pmRNSDirector/PDMR Shareholding
9th Feb 20227:56 amRNSDirector/PDMR Shareholding
4th Feb 20228:32 amRNSHolding(s) in Company
4th Feb 20228:27 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTrading Update
26th Jan 202210:35 amRNSNotice of Trading Update
11th Jan 202211:28 amRNSDirector/PDMR Shareholding
8th Dec 202112:59 pmRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSInvestment in MOMA Foods Limited
29th Nov 20217:00 amRNSTrading Update
8th Nov 20212:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20211:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20219:37 amRNSDirector/PDMR Shareholding
1st Nov 202112:50 pmRNSDirector/PDMR Shareholding
11th Oct 20212:15 pmRNSDirector/PDMR Shareholding
11th Oct 20218:12 amRNSDirector/PDMR Shareholding
1st Oct 20218:49 amRNSDirector/PDMR Shareholding
1st Oct 20218:33 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim results
8th Sep 202111:39 amRNSDirector/PDMR Shareholding
31st Aug 202110:37 amRNSNotice of Interim Results Date
9th Aug 202111:21 amRNSDirector/PDMR Shareholding
3rd Aug 20217:00 amRNSH1 trading update to 1 August 2021
20th Jul 20217:00 amRNSTrading Update
19th Jul 20212:22 pmRNSHolding(s) in Company
9th Jul 20217:55 amRNSDirector/PDMR Shareholding
6th Jul 20213:32 pmRNSDirector/PDMR Shareholding - AMENDMENT
6th Jul 202112:11 pmRNSDirector/PDMR Shareholding
25th Jun 20217:00 amRNSDirectorate Changes
10th Jun 20219:01 amRNSHolding(s) in Company
8th Jun 20213:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.